Search company, investor...

FemtoDx

femtodx.com

Founded Year

2014

About FemtoDx

FemtoDx focuses on the home-based monitoring of cardiovascular diseases with a panel of clinically validated biomarkers. The company specializes in product design, development, and manufacturing in partnership with other companies.

Headquarters Location

8929 Wilshire Blvd. Suite 320

Beverly Hills, California, 90211,

United States

310-734-7750

Missing: FemtoDx's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: FemtoDx's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing FemtoDx

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

FemtoDx is included in 1 Expert Collection, including Health Monitoring & Diagnostics.

H

Health Monitoring & Diagnostics

908 items

At-home IVD test developers, at-home sample collection device developers, at-home testing service providers, and all other companies playing in the at-home testing ecosystem. Companies tagged as #AtHomeTestingEcosystem

FemtoDx Patents

FemtoDx has filed 1 patent.

The 3 most popular patent topics include:

  • Sensors
  • Analytical chemistry
  • Nanotechnology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/14/2019

10/25/2022

Biotechnology, Nanotechnology, Microfluidics, Sensors, Analytical chemistry

Grant

Application Date

11/14/2019

Grant Date

10/25/2022

Title

Related Topics

Biotechnology, Nanotechnology, Microfluidics, Sensors, Analytical chemistry

Status

Grant

Latest FemtoDx News

Global Over-the-Counter (OTC) and Direct-to-Consumer (DTC) Infectious Disease Diagnostics Market Landscape 2020-2024 - FemtoDx Launches Rapid At-Home Test Development for COVID-19

Apr 29, 2020

| Source: Research and Markets Over the Counter and Direct to Consumer diagnostics set to help solve the pandemic problem. New technologies create rapid test solutions for the home market. Self-sampling technology is key. Genetic DTC testing led the way. Now infectious disease testing is moving directly to the consumer. New sampling technology, rapid and multiplex tests have changed the picture on how and where testing is done - and the COVID-19 situation will lead the charge. This report explores the DTC outlook for different syndromes. Find out where the action is and the learn about the players. Exciting technical developments especially in the seesaw between PCR and immunoassay, hold the promise of a dynamic, growing and evolving world market that holds the promise of diagnostics taking the lead in infectious disease eradication. Even CRISPR diagnostics are now coming into play. The report has hundreds of pages of information including a complete list of Current 2019 United States Medicare Fee Payment Schedules to help sharpen your pricing. The report includes detailed breakouts for 15 countries and 4 regions. A detailed breakout for any country in the world is available to purchasers of the report. Key Topics Covered 4.2.3 Wellness Hurts 4.3 Diagnostic Technology Development 4.3.2 NAT vs. Lateral Flow 4.3.3 The Unusual Role of GPS 4.3.4 Self and Send Competition 4.4.5 The Relationship to DTC Genetic 4.4.6 The Relationship to TeleHealth 4.4.7 Sample Collection - Who Knew? 5. OTC/DTC Infectious Disease Testing Recent Developments Recent Developments - Importance and How to Use This Section Importance of These Developments FemtoDx Launches Rapid At-Home Test Development for COVID-19 FDA approves first at-home coronavirus test Free Home HIV Tests Detect More Infections Biohacking trend supports self testing PerkinElmer and EverlyWell to Expand U.S. At-Home Health Test Market Mylan, Atomo Diagnostics Get WHO Prequalification Approval for HIV Self-Test Miraca Holdings Inc. and Seventh Sense Biosystems, Inc. Announce Distribution Agreement OraSure Technologies, Inc. Announces Two Acquisitions Mylan signs HIV test commercialisation deal with Atomo Diagnostics Nigerian Govt Approves Alere HIV Self-Test Kit Rapid HIV tests vary in their accuracy Montreal researchers develop HIV self-testing app Boots launches UTI test and treat service across 37 branches Scanwell Health moves beyond home UTI testing with nationwide kidney disease study partnership Healthy.io raises $18 million for at-home urinalysis tests LetsGetChecked collects $30M more for at-home health testing TestCard, a $4 Urine Test Read by Smartphone Digital Health Startup EverlyWell Raises $50M Thriva adds test-at-home kits for female hormone and cortisol stress Tasso scores $6.1M for patch-based home blood testing LabCorp to offer self-testing home kits 1Drop Diagnostics draws $4.25M for portable blood diagnostic panel DBS Systems HEMAXIS receives CE/IVD mark 211 myLAB Box Announces $1.56M in Seed Funding Abbott HbA1c point-of-care test reliably diagnoses diabetes 6. Profiles of Key Diagnostic Testing Companies 1DropDiagnostics SkylineDx

FemtoDx Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

FemtoDx Rank

FemtoDx Frequently Asked Questions (FAQ)

  • When was FemtoDx founded?

    FemtoDx was founded in 2014.

  • Where is FemtoDx's headquarters?

    FemtoDx's headquarters is located at 8929 Wilshire Blvd., Beverly Hills.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.